Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses

Cell Transplant ◽

Post Transplant

Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma after Autologous Stem Cell Transplant

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-1106 ◽

2004 ◽

Vol 10 (24) ◽

pp. 8170-8176 ◽

Cited By ~ 56

Author(s):

A. Keith Stewart ◽

Christine I. Chen ◽

Kang Howson-Jan ◽

Darrell White ◽

Jean Roy ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Therapy ◽

Phase Ii ◽

Stem Cell Transplant ◽

Phase Ii Trial ◽

Cell Transplant ◽

Randomized Phase Ii

Outcomes of Patients with Multiple Myeloma Following Autologous Stem Cell Transplant According to Post-Transplant Time of Response: A Single Center Experience of 148 Consecutive Transplants

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.07.317 ◽

2019 ◽

Vol 19 ◽

pp. S329

Author(s):

Mohammad Ma'koseh ◽

Mohammad Al-Essa ◽

Husam Abu-Jazar ◽

Khalid Halahleh ◽

Walid Daana ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Single Center ◽

Post Transplant ◽

Single Center Experience

Maintenance Therapy after Autologous Stem Cell Transplant Is Associated with Less Biochemical Relapse in Multiple Myeloma Patients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.616 ◽

2019 ◽

Vol 25 (3) ◽

pp. S378-S379

Author(s):

Rebecca Ye ◽

Petra Martin ◽

Paolo Caimi ◽

Merle Kolk ◽

Leland Metheny ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Therapy ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Biochemical Relapse

Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8523 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8523-8523 ◽

Cited By ~ 9

Author(s):

Sarah A. Holstein ◽

Kouros Owzar ◽

Paul G. Richardson ◽

Chen Jiang ◽

Craig C. Hofmeister ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Therapy ◽

Stem Cell Transplant ◽

Role of Maintenance Therapy After Autologous Stem Cell Transplant for Multiple Myeloma: Lessons for Cancer Therapy

Mayo Clinic Proceedings ◽

10.4065/mcp.2011.0171 ◽

2011 ◽

Vol 86 (5) ◽

pp. 419-420 ◽

Cited By ~ 7

Author(s):

Robert A. Kyle

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Cancer Therapy ◽

Maintenance Therapy ◽

Stem Cell Transplant ◽

A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Older Recently Diagnosed Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.793 ◽

2019 ◽

Vol 25 (3) ◽

pp. S385-S386 ◽

Cited By ~ 1

Author(s):

Christopher Strouse ◽

Kalyan Nadiminti ◽

Jillna Claus ◽

Gabrielle Berns ◽

Allyson Schultz ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Stem Cell Transplant ◽

Phase Ii Trial ◽

Cell Transplant ◽

Post Transplant ◽

Prospective Phase

PB2341 OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT ACCORDING TO POST-TRANSPLANT TIME OF RESPONSE: A SINGLE CENTER EXPERIENCE OF 148 CONSECUTIVE TRANSPLANTS

HemaSphere ◽

10.1097/01.hs9.0000567828.83081.2c ◽

2019 ◽

Vol 3 (S1) ◽

pp. 1043

Author(s):

S. Saadeh ◽

M. Ma’koseh ◽

M. Al-Essa ◽

H. Abu-Jazar ◽

K. Halahleh ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Single Center ◽

Post Transplant ◽

Single Center Experience

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

The Oncologist ◽

10.1634/theoncologist.2017-0440 ◽

2018 ◽

Vol 23 (6) ◽

pp. 734-739 ◽

Cited By ~ 19

Author(s):

Elizabeth Dianne Pulte ◽

Andrew Dmytrijuk ◽

Lei Nie ◽

Kirsten B. Goldberg ◽

Amy E. McKee ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Therapy ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Newly Diagnosed ◽

Fda Approval

Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.8017 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 8017-8017 ◽

Cited By ~ 28

Author(s):

P. L. McCarthy ◽

K. Owzar ◽

K. C. Anderson ◽

C. C. Hofmeister ◽

H. Hassoun ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Therapy ◽

Stem Cell Transplant ◽

Phase Iii ◽

Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma

Bone Marrow Transplantation ◽

10.1038/s41409-019-0663-5 ◽

2019 ◽

Vol 55 (6) ◽

pp. 1188-1190

Author(s):

Mark A. Fiala ◽

Venkata Vosuri ◽

Scott Goldsmith ◽

Mark A. Schroeder ◽

Armin Ghobadi ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Maintenance Therapy ◽

Stem Cell Transplant ◽